Tertius Life Sciences Private Limited
About Tertius Life Sciences Private Limited
Data last updated:
Tertius Life Sciences Private Limited is a private limited company based in Tirur, Kerala, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 18 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24230KL2019PTC060382. Its GSTIN is 32AAHCT6111D1ZV (Kerala).
The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹60.6 Lakh. It is led by directors Mohammed Shea Chullikkattil and Sharika Nafisa.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tirur, Kerala.
As per the financials filed for FY 2024, the company reported a revenue of ₹63.96 Lakh, a growth of 86% compared to the previous year. For the same year it recorded a net loss of ₹30.75 Lakh (net margin -48.1%) and EBITDA of -₹29.4 Lakh (EBITDA margin -46%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Tertius Life Sciences has one previous CIN (Corporate Identification Number): U24230KL2019OPC060382. The current CIN is U24230KL2019PTC060382, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230KL2019PTC060382 | Current |
| U24230KL2019OPC060382 | Previous |
Contact details
Tertius Life Sciences Private Limited's registered office is in Tirur, Kerala. Its e-mail address is in the company report.
- Email
- Registered AddressFirst Floor Building 101, Alinchuvadu, Tirur, Kerala, India – 676101
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Tertius Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tertius Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tertius Life Sciences Private Limited, buy the company report.
Financials of Tertius Life Sciences Private Limited
FY 2025 filings availableTertius Life Sciences Private Limited reported revenue of ₹63.96 Lakh (up 86% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 86% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹29.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹30.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -46% | ||||
| Net Profit Margin | -48.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tertius Life Sciences Private Limited, buy the company report.
Board of directors of Tertius Life Sciences Private Limited
Tertius Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Shea Chullikkattil Also directs: Dyopterus Derma LLP, Dr Prime Healthhub LLP | Director | 18 Nov 2019 | 6 Years 11 Months | Current |
| Sharika Nafisa Also directs: Dyopterus Derma LLP | Director | 15 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Tertius Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seenbless Pharma Private Limited | ₹64.15 Lakh (FY 2024) | 21.0% | New Delhi, Delhi, India | |||
| Generous Technologies Private Limited | ₹64.12 Lakh (FY 2022) | -39.0% | Nagpur, Maharashtra, India | |||
| Mecwel Engineers (India) Private Limited | ₹64.1 Lakh (FY 2025) | -16.0% | Bangalore, Karnataka, India | |||
| Bains Medical Private Limited | ₹64.07 Lakh (FY 2024) | -37.0% | Zirakpur, Punjab, India | |||
| Syglak Laboratories Private Limited | ₹64.04 Lakh (FY 2017) | -75.0% | Badlapur, Maharashtra, India | |||
| Tertius Life Sciences Private Limitedthis company | ₹63.96 Lakh (FY 2024) | -₹30.75 Lakh | -48.1% | 86.0% | Tirur, Kerala, India | |
| 24Kanhaji Pharma Chem Private Limited | ₹63.96 Lakh (FY 2024) | 32.0% | Vadodara, Gujarat, India | |||
| Faveo Life Sciences Private Limited | ₹63.94 Lakh (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Vidi Laboratries Private Limited | ₹63.93 Lakh (FY 2025) | 10.0% | Vadodara, Gujarat, India | |||
| Steadcare Lifesciences Private Limited | ₹63.87 Lakh (FY 2022) | 115.0% | Mohali, Punjab, India | |||
| Kappris Drug Private Limited | ₹63.84 Lakh (FY 2025) | 33.0% | Pune, Maharashtra, India |
To see the full peer comparison of Tertius Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tertius Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tertius Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tertius Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCT6111D1ZV | Kerala | Active | 11 Dec 2019 |
To see the full GST registrations and return filing status of Tertius Life Sciences Private Limited, buy the company report.
Recent activity
Tertius Life Sciences Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Sharika Nafisa was appointed as Director on 15 Apr 2024.
Frequently asked questions
Tertius Life Sciences is an active private limited company based in Tirur, Kerala, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 18 November 2019 (7+ years old) and is registered under CIN U24230KL2019PTC060382.
Tertius Life Sciences has 2 current directors:
- Mohammed Shea Chullikkattil - Director
- Sharika Nafisa - Director
The latest financial statements of Tertius Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Tertius Life Sciences is 32AAHCT6111D1ZV, registered in Kerala.
The CIN (Corporate Identification Number) of Tertius Life Sciences is U24230KL2019PTC060382. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tertius Life Sciences was incorporated on 18 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Tertius Life Sciences by revenue are Seenbless Pharma Private Limited, Generous Technologies Private Limited, Mecwel Engineers (India) Private Limited, Bains Medical Private Limited, Syglak Laboratories Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sharika Nafisa was appointed as Director on 15 Apr 2024. Shirin Shafeek Nachi Veetil ceased to be Additional Director on 15 Apr 2024. Mohammed Shea Chullikkattil was appointed as Director on 18 Nov 2019.
The registered office of Tertius Life Sciences is at First Floor Building 101, Alinchuvadu, Tirur, Kerala, India – 676101.
Tertius Life Sciences operates in the chemicals industry, in the other chemical product segment.
The compliance status of Tertius Life Sciences is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.